BioNexus Gene Lab Corp Common stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $22 | $483 | $2,543 | $2,260 |
Gross Profit | -22 | -3 | 377 | 368 |
EBITDA | -527 | -665 | -569 | |
EBIT | -571 | -708 | -611 | |
Net Income | -543 | -1,036 | -708 | -616 |
Net Change In Cash | 22 | 483 | 2,543 | 2,260 |
Free Cash Flow | -148 | 960 | -1,238 | -759 |
Cash | 3,964 | 4,039 | 2,894 | 814 |
Basic Shares | 2,417 | 2,417 | 1,796 | 1,796 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,424 | $9,510 | $9,770 | $10,928 |
Gross Profit | 1,085 | 1,289 | 1,329 | 1,259 |
EBITDA | -2,796 | -1,420 | -2,485 | -185 |
EBIT | -2,965 | -1,573 | -2,593 | -291 |
Net Income | -2,984 | -1,598 | -2,629 | -355 |
Net Change In Cash | 7,424 | 9,510 | 9,770 | 10,928 |
Free Cash Flow | -1,875 | -2,461 | -1,910 | 489 |
Cash | 2,383 | 4,377 | 5,929 | 2,118 |
Basic Shares | 1,856 | 1,781 | 1,722 | 1,440 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.22 |
2025-12-31 | -$0.52 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.34 |